By Mill Chart
Last update: Jun 27, 2025
BOSTON SCIENTIFIC CORP (NYSE:BSX) stands out as a compelling candidate for investors following the Minervini trend-following strategy while also meeting high-growth investment criteria. The company, a leader in medical device innovation, demonstrates strong technical and fundamental characteristics that align with both momentum and growth investing principles.
Mark Minervini’s strategy focuses on identifying stocks with strong uptrends and relative strength. BSX meets these criteria:
Beyond technical strength, BSX exhibits robust earnings and revenue growth:
According to ChartMill’s technical report, BSX scores a perfect 10/10 on technical health, supported by:
While the setup rating (6/10) suggests some volatility, the overall trend remains favorable for momentum investors.
For a deeper analysis, review the full technical report here.
Our High Growth Momentum + Trend Template screener lists more stocks with similar growth and momentum characteristics.
This is not investment advice. The observations are based on current data, and investors should conduct their own research before making decisions.
104.58
+0.29 (+0.28%)
Find more stocks in the Stock Screener
Boston Scientific Corp (NYSE:BSX) shows strong technical and fundamental growth, fitting Minervini’s trend template with high earnings momentum and improving margins. A top pick for momentum investors.
Boston Scientific Corp (NYSE:BSX) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has solid support levels and consolidation patterns ahead of a potential breakout.